Table 2. The Impact of LMWH Treatment on Pregnancy Complications in Pregnancies Ending in Birth in Women with Conventional Thrombophilias.
Outcome: BIRTH (n=48) Pregnancy complications | Conventional thrombophilias | p value*† | |
---|---|---|---|
No LMWH (n=19), n (%) | LMWH (n=25), n (%) | ||
Preterm birth | 10 (52.6) | 8 (32) | 0.284* |
Fetal growth restriction | 8 (42.1) | 13 (52) | 0.729* |
Preeclampsia | 3 (15.7) | 10 (40) | 0.158* |
Intrauterine fetal death | 5 (26.31) | 0 | 0.011† |
Placental abruption | 3 (15.7) | 3 (12) | 0.682† |
Deep venous thrombosis | 1 (5.26) | 0 | 0.432† |
LMWH, low molecular weight heparin.
*χ2 test, †Fisher's exact test.